Overview
Priscilla Brastianos is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Brastianos is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). Her top areas of expertise are Brain Tumor, Metastatic Brain Tumor, Melanoma, and Posterior Fossa Tumor.
Her clinical research consists of co-authoring 214 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
55 Fruit St, Boston, MA 02114
Additional Areas of Focus
Dr. Brastianos has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Dana-Farber Cancer Institute, Center For Neuro-Oncology
David Reardon is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Reardon is rated as an Elite provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy.
Dana-Farber Cancer Institute, Breast Oncology Program
Dr. Varella is a clinical expert in the care of patients with breast cancer. She was born in Sao Paulo, Brazil where she completed her training in Medical Oncology. She moved to the United States for a research fellowship in cancer Immunology at the Cleveland Clinic, followed by a clinical fellowship in Experimental Therapeutics. Following her residency in Internal Medicine, she spent a year as a Chief Resident at Memorial Sloan Kettering Cancer Center. She then completed a fellowship in Hematology & Oncology at the Cleveland Clinic.After her training, Dr. Varella joined the breast cancer group coming from Weill Cornell Medical College in New York where she was an Assistant Professor of Medicine specialized in the treatment of breast cancer. Dr. Varella has a special clinical and research focus on improving outcomes in young patients with breast cancer. Her recent research innovations include leading a project at DFCI in which she is investigating the factors associated with survival in young patients with metastatic breast cancer from the Young Women’s Breast Cancer study (YWS) at DFCI. She also supervises and teaches Internal Medicine residents and Medical Oncology fellows at DFCI. Dr. Varella is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). Her top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Breast Cancer.
Dana-Farber Cancer Institute, Inc.
Lakshmi Nayak is an Oncologist and a Neurologist in Boston, Massachusetts. Dr. Nayak is rated as an Elite provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). Her top areas of expertise are Astrocytoma, Glioma, Glioblastoma, and Brain Tumor. Dr. Nayak is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Brain TumorDr. Brastianos isElite. Learn about Brain Tumor.
- Metastatic Brain TumorDr. Brastianos isElite. Learn about Metastatic Brain Tumor.
- Distinguished
- Lung AdenocarcinomaDr. Brastianos isDistinguished. Learn about Lung Adenocarcinoma.
- MelanomaDr. Brastianos isDistinguished. Learn about Melanoma.
- Posterior Fossa TumorDr. Brastianos isDistinguished. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Brastianos isDistinguished. Learn about Primitive Neuroectodermal Tumor (PNET).
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Brastianos isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AstrocytomaDr. Brastianos isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Brastianos isAdvanced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Breast CancerDr. Brastianos isAdvanced. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Brastianos isAdvanced. Learn about EGFR Positive Lung Cancer.
- Embryonal Tumor with Multilayered Rosettes
- Experienced
- Anal CancerDr. Brastianos isExperienced. Learn about Anal Cancer.
- Anaplastic Thyroid CancerDr. Brastianos isExperienced. Learn about Anaplastic Thyroid Cancer.
- Bone TumorDr. Brastianos isExperienced. Learn about Bone Tumor.
- Brain Stem CancerDr. Brastianos isExperienced. Learn about Brain Stem Cancer.
- Choroid Plexus CarcinomaDr. Brastianos isExperienced. Learn about Choroid Plexus Carcinoma.
- Dysembryoplastic Neuroepithelial Tumors (DNET)Dr. Brastianos isExperienced. Learn about Dysembryoplastic Neuroepithelial Tumors (DNET).